Seacross Pharmaceutical Co Ltd | Sichuan Huiyu Pharmaceuticals Co., Ltd. - API Manufacturing Site

The API Manufacturing Site consists of 20 specialized workshops dedicated to the development and commercial production of a wide variety of active pharmaceutical ingredients (APIs).

Key capabilities include:

• Oncology APIs
• Cytotoxic APIs
• High Potent APIs (OEB 5)
• Sterile APIs
• Automatic fermentation lines for biosimilars
• Dedicated production areas for peptides and mRNA-based products

The reaction workshops are divided into large, medium, and small-scale production zones, along with classified clean areas to ensure flexibility and strict adherence to regulatory requirements. A dedicated strain cultivation room further supports fermentation and biologics manufacturing.

The facility supports batch sizes ranging from laboratory and pilot scale to full-scale commercial production. It is equipped with advanced systems, including MSGL, stainless steel, titanium, and glass reactors with volumes ranging from 100 L to 5,000 L.

Our technical capabilities cover a wide process range, including:

• Ultra-low to ultra-high temperature reactions
• Molecular and high vacuum distillation
• Solvent recovery and waste treatment
• Membrane-based gas separation
• Hydrogenation

The site has successfully passed multiple production license inspections, covering China NMPA, EU EMA and US FDA, among others.